GLP-1 inhibits gastric emptying of water but does not influence plasma.
BACKGROUND
Glucagon-like peptide-1 (GLP-1) has been shown to inhibit gastric emptying of a caloric load but the effect on a non-caloric load is unknown.


METHODS
Seven healthy men were studied after an over-night fast. Thirty min before the intake of 330 ml radioactively labeled water either GLP-1 (0.75 pmol/kg/min) or saline was administered intravenously and continued for 75 min. Scintigraphic gastric emptying was performed for 45 min and plasma samples were obtained for analysis of vasopressin, sodium, osmolality, GLP-1, insulin, and glucose. In addition, electric field stimulation of human gastric muscle strips was done.


RESULTS
The median (range) percent water retained in the stomach, 45 min after intake of water, was 96% (68%-98%) and 12% (2%-42%) (P = 0.02) during infusion of GLP-1 and saline, respectively. Additionally, GLP-1 did not affect basal tone or contractile response of gastric muscle strips to electric field stimulation or acetylcholine (ACh). There was no change in plasma concentrations of vasopressin, sodium, or plasma osmolality during GLP-1 compared to saline infusion.


CONCLUSIONS
GLP-1 has a profound inhibitory effect on the gastric emptying of water in man, but no short-term effect on water homeostasis. No effect was seen on contractility of gastric muscle strips suggesting an indirect action on gastric emptying.
Näslund
E
E
Dept. of Surgery, Danderyd Hospital, Sweden. Erik.Naslund@kir.ds.sll.se
Bogefors
J
J
Grybäck
P
P
Bjellerup
P
P
Jacobsson
H
H
Holst
J J
JJ
Hellström
P M
PM
D000109:Acetylcholine / Q000494:pharmacology; D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D005746:Gastric Emptying / Q000187:drug effects*; D005934:Glucagon / Q000097:blood / Q000494:pharmacology*; D052216:Glucagon-Like Peptide 1; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood; D008297:Male; D009994:Osmolar Concentration; D010446:Peptide Fragments / Q000097:blood / Q000494:pharmacology*; D011498:Protein Precursors / Q000097:blood / Q000494:pharmacology*; D012964:Sodium / Q000097:blood*; D014667:Vasopressins / Q000097:blood*
D001786:Blood Glucose; D007328:Insulin; D010446:Peptide Fragments; D011498:Protein Precursors; D014667:Vasopressins; D052216:Glucagon-Like Peptide 1; D005934:Glucagon; D012964:Sodium; D000109:Acetylcholine